Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were presented at the Society ...
May 3, 2024
0
0
With 23 Grand Slam singles titles to her name, Serena Williams is among the greatest tennis players of all-time. It made her wealthy, too, amassing an estimated net worth of $300 million.
Apr 23, 2024
0
0
A new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled " Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty," advocates for additional research ...
Mar 18, 2024
0
1
The rate of venous thromboembolism is increased in association with cancer surgery, according to a study published online Feb. 2 in JAMA Network Open.
Feb 2, 2024
0
2
An analysis of more than 1.6 million emergency department (ED) visits for acute pulmonary embolism (PE) has found that nearly two-thirds of ED visits still resulted in hospitalization for low-risk patients. This trend remained ...
Jan 29, 2024
0
7
In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part ...
Jan 29, 2024
0
0
Mechanical thrombectomy (MT) is safe and effective in real-world, high-risk patients with pulmonary embolism (PE), according to a study published online Oct. 31 in the Journal of the Society for Cardiovascular Angiography ...
Dec 10, 2023
0
1
The BASHIR Endovascular Catheter (THROMBOLEX, Inc.), recently approved by the U.S. Food and Drug Administration (FDA), is paving the way to more effective and safe treatment for acute pulmonary embolism.
Dec 4, 2023
0
1
New research from the FLASH registry shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism. The study, titled "Mechanical Thrombectomy for High-risk Pulmonary Embolism: ...
Oct 31, 2023
0
1
A trial emulation study of veterans with COVID-19 has found that the use of the antiviral nirmatrelvir–ritonavir was not effective for reducing the risk for many post-COVID-19 conditions, including cardiac, pulmonary, renal, ...
Oct 30, 2023
0
2
